Point of Care (POC) Molecular Diagnostics - Global Strategic Business Report

The global market for Point of Care (POC) Molecular Diagnostics is estimated at US$3.7 Billion in 2023 and is projected to reach US$8.8 Billion by 2030, growing at a CAGR of 11.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the PCR-based Molecular Diagnostics segment, which is expected to reach US$5.7 Billion by 2030 with a CAGR of 12.1%. The Genetic Sequencing-Based Molecular Diagnostics segment is also set to grow at 9.1% CAGR over the next 8 years.
• Regional Analysis: Gain insights into the U.S. market, estimated at $1.5 Billion in 2023, and China, forecasted to grow at an impressive 13.8% CAGR to reach $1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Point of Care (POC) Molecular Diagnostics Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Point of Care (POC) Molecular Diagnostics Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Point of Care (POC) Molecular Diagnostics Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Bayer AG, Danaher Corporation, DiaSorin SpA, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 64 Featured):

• Bayer AG
• Danaher Corporation
• DiaSorin SpA
• Biocartis NV
• Maxim Biomedical, Inc.
• AccuBioTech Co., Ltd.
• Abacus Diagnostica Oy
• genedrive plc
• Molbio Diagnostics Pvt. Ltd.
• Mesa Biotech, Inc.
• Binx Health
• Credo Diagnostics Biomedical Pte. Ltd
• Genestat Molecular Diagnostics, LLC
• Alveo Technologies
• ADOR Diagnostics

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.